Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.

doi:10.1016/j.ejca.2017.04.026

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.

European journal of cancer (Oxford, England : 1990) - 1 Aug 2017

Thomsen Maria, Guren Marianne Grønlie, Skovlund Eva, Glimelius Bengt, Hjermstad Marianne Jensen, Johansen Julia S, Kure Elin, Sorbye Halfdan, Pfeiffer Per, Christoffersen Thoralf, Guren Tormod Kyrre, Tveit Kjell Magne

Abstract excerpt

BACKGROUND: The aim of this study was to evaluate the effect of cetuximab on health-related quality of life (HRQoL) in the NORDIC-VII trial on metastatic colorectal cancer (mCRC), and to assess HRQoL in relation to RAS and BRAF mutation status and inflammatory biomarkers. PATIENT AND METHODS: HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Reactive Protein

Share to Cetuximab

Share to Cisplatin

Share to GTP Phosphohydrolases

Share to Health Status

Share to Proto-Oncogene Proteins p21(ras)

Share to Quality of Life

Source

Open in PubMed

Identifiers

PMID: 28595137
DOI: 10.1016/j.ejca.2017.04.026

Genes

BRAF
CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status.PMID 28595137Read ↗

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.Semantic proximity Read ↗

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.Semantic proximity Read ↗

Chemotherapy ± cetuximab modulates peripheral immune responses in metastatic colorectal cancer.Semantic proximity Read ↗

Effect of Antiangiogenic-Based Treatment and Systemic Inflammatory Factors on Outcomes in Patients With BRAF v600-Mutated Metastatic Colorectal Cancer: A Real-World Study in SpainSemantic proximity Read ↗

Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survivalSemantic proximity Read ↗

The Demographic Profile of Colorectal Cancer Patients in Indonesia: Insights from a Single Center Experience and Exploration of Immune Response and Survival OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.